Subscribe to RSS
Download PDF
DOI: 10.1055/s-0038-1629837
PET Imaging of Recurrent Medullary Thyroid Cancer[*]
Publication History
Received:
25 October 1995
in revised form:
18 December 1995
Publication Date:
04 February 2018 (online)
Summary
Medullary carcinoma of the thyroid gland is a rare tumor. Its prognosis is mainly linked to surgery, because there is no valid alternative therapy to improve patients outcome. In this report, we discuss the recurrence of such a tumor in a 64-year-old female, focusing on magnetic resonance imaging and positron emission tomography evaluation of this tumor.
Zusammenfassung
Das medulläre Schilddrüsenkarzinom ist ein seltener Tumor. Seine Prognose wird maßgeblich durch die frühzeitige operative Entfernung des Tumorgewebes bestimmt, weil alternative Therapieformen zur Verbesserung der Prognose nicht zur Verfügung stehen. Im vorliegenden Fallbericht werden am Beispiel einer 64jährigen Patientin die Möglichkeiten der Kernspintomographie und der Positronen-Emissions-Tomographie in der Diagnostik des Rezidivs diskutiert.
* Dedicated to Prof. Dr. W. Wenz on the occasion of his 70th birthday
-
REFERENCES
- 1 Auffermann W, Clark OH, Thurnher S, Galante M, Higgins CB. Recurrent thyroid carcinoma: characteristics on MR images. Radiology 1988; 168: 753-7.
- 2 Chong GC, Beahrs OH, Sizemore GW, Woolner LB. Medullary carcinoma of the thyroid gland. Cancer 1975; 35: 695-704.
- 3 Feine U, Lietzenmayer R, Hanke JP, Wöhrle H, Müller-Schauenburg W. 18FDG-Ganzkor-per-PET bei differenzierten Schilddrüsenkarzinomen. Nuklearmedizin 1995; 34: 127-34.
- 4 Gorman B, Charboneau JW, James EM, Reading CC, Wold LE, Grant CS, Gharib H, Hay ID. Medullary thyroid carcinoma: role of high-resolution US. Radiology 1987; 162: 147-50.
- 5 Hamberg LM, Hunter GJ, Alpert NM, Noah CC, Babich JW, Fischman AJ. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification. J Nucl Med 1994; 35: 1308-12.
- 6 Mc Cook TA, Putman CE, Dale JK, Wells SA. Medullary carcinoma of the thyroid: Radiographic features of a unique tumor. AJR 1982; 139: 149-55.
- 7 Raue F, Winter J, Frank-Raue K, Lorenz D, Herfarth C, Ziegler R. Diagnostic procedure before reoperation in patients with medullary thyroid carcinoma. Horm Metab Res Suppl 1989; 21: 123-31.
- 8 Reiners C. Imaging methods of medullary thyroid cancer. In: Recent results in cancer research. Vol. 125. Berlin, Heidelberg: Springer-Verlag; 1992
- 9 Saad ME, Ordonez NG, Rashid RK. et al. Medullary carcinoma of the thyroid: a study of the clinical features and prognostic factors in 161 patients. Medicine 1984; 63: 319-42.
- 10 Schwerk WB, Grun R, Wahl R. Ultrasound diagnosis of C-cell carcinoma of the thyroid. Cancer 1985; 55: 624-30.
- 11 Simeone JF, Daniels GH, Hall DA, McCarthy K, Kopans DB, Butch RJ, Mueller PR, Stark DD, Ferrucci JT, Wang CA. Sonography in the follow-up of 100 patients with thyroid carcinoma. AJR 1987; 148: 45-9.
- 12 Sutton RT, Reading CC, Charboneau JW, James EM, Grant CS, Hay ID. US-guided biopsy of neck masses in postoperative management of patients with thyroid cancer. Radiology 1988; 168: 769-72.